NCT07583238Not yet recruiting
Diathermy On Diabetes Glucose Monitoring Effectiveness
Assessing the Impact of Intraoperative Diathermy on Accuracy and Functioning of Glucose Monitoring Systems
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
The goal of this observational study is to investigate if diathermy (a surgical tool that uses electrical energy to control bleeding) has any affect on the accuracy and functioning of continuous glucose monitoring systems in adults and young people with Type 1 Diabetes. The main questions this study aims to answer is - \- Does the accuracy of continuous glucose monitoring systems change after use of diathermy? Participants will: * Have their height and weight checked. * Provide information about their medical history including type of diabetes, other medical conditions and any current medications they take. * Have paired glucose meter and sensor glucose measurements taken every 15-75 minutes from up to 4 hours before surgery until up to 4 hours after the end of surgery. * Have two blood samples taken to measure glucose levels, The first one will be before the use of diathermy and the second will be after the use of diathermy.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 126 (estimated)
- First submitted
- 13 Apr 2026
- Start date
- May 2026
- Primary completion date
- Feb 2027
- Lead sponsor
- University of Nottingham
- Diseases
- Type 1 diabetes
- NCT number
- NCT07583238
What you commit to
- Study type: Observational
- Planned participants: 126
- From May 2026 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of paracetamol above maximum dose within 7 days before the scheduled date of surgery (in adults with body weight under 51kg - maximum of 60mg/kg per day, in adults with body weight 51kg and above - maximum of 4g per day, in children - maximum dose as per their age as stated in the British National Formulary for Children)
- Any use of hydroxyurea within 7 days before the scheduled date of surgery
- Use of more than 500mg per day of ascorbic acid / vitamin C within 7 days before the scheduled date of surgery
- Currently taking medications as part of a clinical trial.
Who the study is looking for
- Diagnosis of type 1 diabetes mellitus.
- Planned admission for elective surgery at Nottingham University Hospitals NHS Trust.
- Currently routinely using a prescribed Abbott Libre-2, Abbott Libre-3, Dexcom G6 or Dexcom G7 glucose monitoring system to monitor glucose concentrations.
- Aged 4 years or older on the day of surgery.
- Ability to give informed consent / ability of parent/carer to give informed consent (as appropriate).
Age in the registry: 4 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Queen'S Medical Centre Coordinator of this site? Confirm its status | Nottingham | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.